62689-51-4

Basic information

• Product Name: 1-DIMETHYLAMINO-2-PROPYLAMINE 98
• Synonyms: 1-DIMETHYLAMINO-2-PROPYLAMINE 98;(1)-N1,N1-Dimethylpropane-1,2-diamine;1,2-Propanediamine, N',N'-dimethyl-, (+-)-;1,2-Propanediamine, N1,N1-dimethyl-;Einecs 203-555-9;Einecs 263-699-3;Nsc 166323
• CAS NO: 62689-51-4
• Molecular Formula: C5H14N2
• Molecular Weight: 102.18
• EINECS: 263-699-3
• Mol File: 62689-51-4.mol
• Article Data: 9

Chemical Properties

• Melting Point: 35.18°C
• Boiling Point: 113 °C(lit.)
• Flash Point: 95 °F
• Appearance: /
• Density: 0.792 g/mL at 25 °C(lit.)
• Vapor Pressure: 27.6mmHg at 25°C
• Refractive Index: n20/D 1.421(lit.)
• CAS DataBase Reference: 1-DIMETHYLAMINO-2-PROPYLAMINE 98(CAS DataBase Reference)
• NIST Chemistry Reference: 1-DIMETHYLAMINO-2-PROPYLAMINE 98(62689-51-4)
• EPA Substance Registry System: 1-DIMETHYLAMINO-2-PROPYLAMINE 98(62689-51-4)

Safety Data

• Hazard Codes: C
• Statements: 22-37/38-41
• Safety Statements: 26-36/37/39-45
• RIDADR: UN 2734 8/PG 2
• WGK Germany: 3
• HazardClass: 8
• PackingGroup: II
• Hazardous Substances Data: 62689-51-4(Hazardous Substances Data)

Usage

General Description

1-Dimethylamino-2-propylamine, approximately 98% pure, is an organic compound that falls under the category of alkylamines. It is composed of carbon, hydrogen, and nitrogen elements. This chemical is primarily used as a building block or intermediate in the synthesis of other complex organic compounds. It is often utilized in the pharmaceutical industry, particularly in the generation of compounds with potential therapeutic efficacy. Its structure consists of a primary amine group and a secondary amine group, contributing to its reactivity and chemical properties. This chemical requires careful handling due to its corrosive nature and potential harm it can cause to the eyes, skin, and respiratory system.

InChI:InChI=1/C5H14N2/c1-5(6)4-7(2)3/h5H,4,6H2,1-3H3

Upstream product

• 108-16-7 1-methyl-2-N,N-dimethylaminoethanol 
• 15364-56-4 dimethylaminoacetone 
• 230643-51-3 (R)-2-amino-N,N-dimethylpropanamide 
• 125218-78-2 tert-butyl (S)-[1-(dimethylamino)-1-oxopropan-2-yl]carbamate 
• 42718-51-4 (S)-benzyl 1-(dimethylamino)-1-oxopropan-2-ylcarbamate 
• 82111-44-2 leucinostatin A 
• 15761-38-3 L-N-Boc-Ala 
• 124-40-3 dimethyl amine 
• 76600-38-9 P₁₆₈ 

Downstream Products

• 39265-07-1 N-(1-methyl-2-dimethylaminoethyl)-2,2'-dihydroxy-diphenylketoimin 
• 93697-26-8 N-((S)-2-Dimethylamino-1-methyl-ethyl)-benzamide 
• 6515-61-3 3-(4-chloro-phenethyl)-5-(2-dimethylamino-1-methyl-ethyl)-[1,3,5]thiadiazinane-2-thione 

Relevant articles and documents

SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS

Disclosed herein are compounds that selectively bind an expanded transcribed repeat r(G4C2)exp, prevent sequestration of RNA-binding proteins, and inhibit translation of repeat associated non-ATG (RAN) translation responsible for generation of toxic dipeptide repeats underlying diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The compounds and their pharmaceutical compositions are useful in treating a disease or condition characterized by an expanded G4C2 repeat RNA (r(G4C2)exp), such as ALS and FTD.

NOVEL TRIFLUOROMETHYL-OXADIAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

The invention relates to novel trifluoromethyl-oxadiazole derivatives of formula (I), and pharmaceutically acceptable salts thereof, (I) in which all of the variables are as defined in the specification, pharmaceutical compositions thereof, pharmaceutical combinations thereof, and their use as medicaments, particularly for the treatment of neurodegeneration, muscle atrophy or metabolic syndrome via inhibition of HDAC4.

An efficient and general synthesis of primary amines by ruthenium-catalyzed amination of secondary alcohols with ammonia

Atom efficiency and selectivity are the key features of the first homogeneously catalyzed amination of secondary alcohols with ammonia to give the corresponding primary amines (see scheme). This novel amination method relies on the commercially available catalyst [Ru3(CO)12]/ cataCXium PCy and does not require any additional source of hydrogen.